₹ 216.25
-1.17 (-0.54%)
J
Jagsonpal Pharmaceuticals
₹ 216.25
Jagsonpal Pharmaceuticals EPS Summary
The latest quarterly EPS of Jagsonpal Pharmaceuticals as of Q2 Sep 2026 stands at ₹1.91. This is a 4.50% fall quarter on quarter and 1.60% growth same quarter last year. For the FY2026 the EPS of Jagsonpal Pharmaceuticals stands at ₹6.40. This is a 22.52% fall compared with FY2025.
Jagsonpal Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

